Sinsin Pharmaceutical Co. Ltd (002800) — Financial Flexibility Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of ₩5.57 Billion (operating CF ₩4.70 Billion minus capex ₩871.54 Million) represents 0% of total liabilities (₩65.10 Billion). Check 002800 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Sinsin Pharmaceutical Co. Ltd.
Annual Financial Flexibility Index for Sinsin Pharmaceutical Co. Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Sinsin Pharmaceutical Co. Ltd. Explore 002800 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | ₩7.46 Billion | ₩5.94 Billion | ₩63.61 Billion | ▼ -18.4% |
| 2023 | 0.14x | ₩8.96 Billion | ₩3.93 Billion | ₩62.32 Billion | ▲ +38.9% |
| 2022 | 0.10x | ₩6.37 Billion | ₩5.46 Billion | ₩61.52 Billion | ▲ +127.2% |
| 2021 | 0.05x | ₩2.71 Billion | ₩23.18 Million | ₩59.38 Billion | ▼ -79.6% |
| 2020 | 0.22x | ₩13.83 Billion | ₩1.87 Billion | ₩61.94 Billion | ▲ +1.7% |
| 2019 | 0.22x | ₩16.00 Billion | ₩-4.51 Billion | ₩72.87 Billion | ▼ -55.3% |
| 2018 | 0.49x | ₩26.21 Billion | ₩774.24 Million | ₩53.38 Billion | ▲ +61.3% |
| 2017 | 0.30x | ₩8.14 Billion | ₩4.57 Billion | ₩26.74 Billion | ▲ +2.4% |
| 2016 | 0.30x | ₩10.22 Billion | ₩2.79 Billion | ₩34.38 Billion | — |